GURUFOCUS.COM » STOCK LIST » Creative Antibiotics AB (OSTO:CAS) » Definitions » Tax Expense

Creative Antibiotics AB (OSTO:CAS) Tax Expense : kr0.00 Mil (TTM As of Mar. 2013)


View and export this data going back to . Start your Free Trial

What is Creative Antibiotics AB Tax Expense?

Creative Antibiotics AB's tax expense for the months ended in Mar. 2013 was kr0.00 Mil. Its tax expense for the trailing twelve months (TTM) ended in Mar. 2013 was kr0.00 Mil.


Creative Antibiotics AB Tax Expense Historical Data

The historical data trend for Creative Antibiotics AB's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Antibiotics AB Tax Expense Chart

Creative Antibiotics AB Annual Data
Trend Jun08 Jun09 Jun10 Dec11
Tax Expense
- - - -

Creative Antibiotics AB Quarterly Data
Jun08 Mar09 Jun09 Sep09 Dec09 Mar10 Sep10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Mar13
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Creative Antibiotics AB Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Mar. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Creative Antibiotics AB  (OSTO:CAS) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Creative Antibiotics AB Tax Expense Related Terms

Thank you for viewing the detailed overview of Creative Antibiotics AB's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.